A Long-term Extension Study of Dazodalibep in Participants With Sjgren's Syndrome (SS)

Status:
RECRUITING

Trial end date:
2029-08-26

Target enrollment:

Participant gender:

The primary objective of this study is to evaluate the long-term safety and tolerability of dazodalibep.

PHASE3

Amgen